WebJul 27, 2024 · FREMONT, Calif., July 27, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, announced today the ... WebOct 26, 2024 · Cytek is headquartered in Fremont, California with offices and distribution channels across the globe. More information about the company and its products is …
Investor Relations Cytek Biosciences
WebFeb 28, 2024 · Investor Relations Cytek Biosciences Investor Relations Incorporating innovative technology inspired by the telecom industry the Cytek® Aurora and Northern … Presentations - Investor Relations Cytek Biosciences Cytek Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on … SEC Filings - Investor Relations Cytek Biosciences Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from … Wenbin Jiang, Ph.D. has served as Cytek’s Chief Executive Officer and a member of … Annual Reports - Investor Relations Cytek Biosciences Cytek was incorporated in Delaware in 2014 under the name Cytoville, Inc. In August … WebFeb 13, 2024 · Cytek Biosciences is registered under the ticker NASDAQ:CTKB . Their stock opened with $17.00 in its Jul 23, 2024 IPO. … cybersoc
Cytek Biosciences Reports Fourth Quarter and Full Year 2024 …
WebThe Investor Relations website contains information about Cytek Biosciences's business for stockholders, potential investors, and financial analysts. WebFeb 13, 2024 · An existing installed base of more than 7,000 instruments will be under the Cytek umbrella following the acquisition, expanding the company’s global commercial … WebOct 26, 2024 · Therefore, investors should monitor Cytek’s website, LinkedIn page, and Twitter account in addition to following its SEC filings, news releases, public conference calls and webcasts. Investor Relations Contact: Paul D. Goodson Head of Investor Relations [email protected]. Media Contact: Stephanie Olsen Lages & Associates (949) … cybersn boston